genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Bioprocessing

      Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

      Blood cells
      Infectious Diseases

      Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

      Antibody Immunoglobulin
      Antibodies

      Broad Range Antibodies Neutralize All SARS-CoV-2 Variants and Other Coronaviruses

      Mitochondria
      Mitochondrial Diseases

      Novel Insights into the Organization of Proteins in Mitochondria

      Target Identification

      Prairie Vole Study Raises Questions on Role of Oxytocin in Social…

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Antibodies

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Bioprocessing

      Cell and Gene Therapy Scale-Up Challenges

      Bioprocessing

      Making Molecules Instead of Growing Them

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Drug Discovery Target Identification

Target Identification

  • ADME/TOX
  • Antibodies
  • Assay Development
  • Cell-Based Assays
  • Drug Delivery
  • Drug Interactions
  • Drug Repositioning
  • Druggable Genome
  • GPCRs
  • High-Content Analysis
  • High-Content Screening
  • High-Throughput Screening
  • Outsourcing
  • Small Molecules
  • Target Identification
  • Therapeutics
  • Vaccine Development
    Most popular
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Target Identification

    Parkinson’s Disease Drug That Cools “Brains on Fire” Could Enter Human Trials in 2020

    Target Identification

    Anti-Obesity “Biochemical Cigarette” Exploits Body’s Responses to Cold and Smoking

    Fear
    Target Identification

    Fear in Mind: Coping Mechanism Identified in New Brain Region

    Target Identification

    Softening Up Chemo-Resistant Cancer Cells

    The novel molecule IMP-1088 (yellow) blocks human NMT (blue)
    Target Identification

    Common Cold Blocked from Replicating by Novel Drug Molecule

    Source: Scientific Animations Inc., [(CC BY-SA 4.0)
    Target Identification

    Cannabis Combo Therapy Triples Pancreatic Cancer Survival Rate

    Source:  Mikhail Goldenkov / Strelka Institute
    Target Identification

    Exercise Pathway That Regulates Muscle Remodeling May Have Implications for Metabolic...

    Target Identification

    CRISPR Human Knockout Screens Identify New Target for ALS

    Target Identification

    Testicular Cancer Mapped Genomically and Epigenomically

    Target Identification

    Newly Uncovered Pathway Points to New Strategies Against Ovarian Cancer

    Depiction of the molecular processes involved in a new subtype of metastatic prostate cancer characterized by loss of the gene CDK12. [Alexander Tokarev/Ella Maru Studio]
    Target Identification

    New Prostate Cancer Subtype Identified, Responsive to Immunotherapy

    Molecularly stained brain cells shows the AMPK target protein (green) in a large glioblastoma brain tumor that grew from transplanted human cancer cells in a mouse brain. Scientists report in Nature Cell Biology that tumor growth was reduced when the researchers genetically inhibited AMPK
    Target Identification

    Aggressive Brain Cancer Can Be Driven by Tumor Suppressor

    Target Identification

    UCB Acquires Element Genomics, with Targeted Therapies in Mind

    Treated prostate cancer cells. [Mateus Crespo/Professor Johann de Bono/ICR]
    Target Identification

    Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy

    Source: AJC1/Flickr
    Target Identification

    Noncoding RNA Drug Target for Colon Cancer Discovered

    123...21Page 1 of 21

    Recently Featured

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

    Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

    Novel Insights into the Organization of Proteins in Mitochondria

    Novel Insights into the Organization of Proteins in Mitochondria

    Prairie Vole Study Raises Questions on Role of Oxytocin in Social Attachment

    Prairie Vole Study Raises Questions on Role of Oxytocin in Social Attachment

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up